We are live on
!
Find out more
1C
111 Capital Portfolio holdings
AUM
$582M
1-Year Est. Return
40.52%
This Fund
S&P 500
This Quarter
Est. Return
-1.64%
1 Year Est. Return
+40.52%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$406M
AUM Growth
-$52.5M
(-11%)
Cap. Flow
-$30.1M
Cap. Flow
% of AUM
-7.43%
Top 10 Holdings %
Top 10 Hldgs %
35.01%
Holding
479
New
157
Increased
85
Reduced
86
Closed
151
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$17.5M |
| 2 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$9.14M |
| 3 |
iShares Semiconductor ETF
SOXX
|
+$8.51M |
| 4 |
Vanguard Real Estate ETF
VNQ
|
+$4.54M |
| 5 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$4.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$33.5M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$22.8M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$7.75M |
| 4 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$5.87M |
| 5 |
Cisco
CSCO
|
+$3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.59% |
| 2 | Healthcare | 11.62% |
| 3 | Communication Services | 10.07% |
| 4 | Consumer Discretionary | 9.3% |
| 5 | Financials | 7.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Lam Research
LRCX
$389B
| $2.6M | 0.64% |
12,147
+3,262
| +37% | +$729K |
|
27
Eli Lilly
LLY
$1.03T
| $2.56M | 0.63% |
2,786
+756
| +37% | +$766K |
|
28
Amgen
AMGN
$221B
| $2.5M | 0.62% |
7,110
+2,020
| +40% | +$720K |
|
29
Coca-Cola Europacific Partners
CCEP
$47.4B
| $2.31M | 0.57% |
25,458
+3,304
| +15% | +$317K |
|
30
Deutsche Bank
DB
$71.2B
| $2.3M | 0.57% |
79,240
-24,790
| -24% | -$873K |
|
31
Intel
INTC
$507B
| $2.25M | 0.55% |
50,894
+13,187
| +35% | +$604K |
|
32
Intuitive Surgical
ISRG
$131B
| $2.2M | 0.54% |
4,782
-876
| -15% | -$443K |
|
33
Analog Devices
ADI
$183B
| $2.14M | 0.53% |
6,714
+2,285
| +52% | +$727K |
|
34
State Street Materials Select Sector SPDR ETF
XLB
$8.61B
| $2.08M | 0.51% |
41,613
-22,351
| -35% | -$1.12M |
|
35
PepsiCo
PEP
$189B
| $2.03M | 0.5% |
13,077
-13,506
| -51% | -$2.1M |
|
36
Texas Instruments
TXN
$254B
| $2.01M | 0.49% |
10,334
+4,812
| +87% | +$974K |
|
37
Linde
LIN
$226B
| $1.95M | 0.48% |
3,925
-1,006
| -20% | -$475K |
|
38
KLA
KLAC
$252B
| $1.93M | 0.48% |
13,120
+1,560
| +13% | +$228K |
|
39
Visa
V
$686B
| $1.77M | 0.44% |
5,862
+490
| +9% | +$158K |
|
40
Devon Energy
DVN
$49.2B
| $1.73M | 0.43% |
+34,467
| New | +$1.48M |
|
41
Cintas
CTAS
$80.1B
| $1.73M | 0.43% |
10,244
+6,488
| +173% | +$1.24M |
|
42
JPMorgan Chase
JPM
$956B
| $1.69M | 0.42% |
+5,757
| New | +$1.75M |
|
43
Philip Morris
PM
$290B
| $1.69M | 0.42% |
+10,211
| New | +$1.77M |
|
44
Ecolab
ECL
$79.5B
| $1.68M | 0.41% |
6,308
+5,167
| +453% | +$1.46M |
|
45
Vertex Pharmaceuticals
VRTX
$122B
| $1.67M | 0.41% |
3,740
+848
| +29% | +$395K |
|
46
AbbVie
ABBV
$436B
| $1.63M | 0.4% |
7,504
+62
| +0.8% | +$13.8K |
|
47
UnitedHealth
UNH
$375B
| $1.58M | 0.39% |
5,834
+1,214
| +26% | +$362K |
|
48
Sysco
SYY
$40.4B
| $1.56M | 0.39% |
21,934
+16,877
| +334% | +$1.4M |
|
|
49
State Street Utilities Select Sector SPDR ETF
XLU
$22.5B
| $1.56M | 0.38% |
33,914
-130,739
| -79% | -$5.87M |
|
50
Constellation Energy
CEG
$94.7B
| $1.49M | 0.37% |
5,329
+2,453
| +85% | +$745K |
|
Similar funds
IIA
DLCIG
TCMX
TCM
JCP
AF
AIM
KI
111 Capital's Q1 2026 Portfolio in Review
As of Q1 2026, 111 Capital held 479 positions worth $406M, down 11% from $458M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
111 Capital withdrew a net $30.1M in Q1 2026, closing 151 positions and reducing 86 holdings. Its most notable exit was State Street SPDR Dow Jones Industrial Average ETF Trust, an estimated $33.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, 111 Capital opened a new position in iShares Semiconductor ETF worth $8.2M.
- 111 Capital's largest Q1 2026 buy was iShares Semiconductor ETF: 24,935 shares worth $8.2M.
- 111 Capital added most to AstraZeneca in Q1 2026, an estimated $17.5M increase.
- 111 Capital's biggest Q1 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $22.8M.
- 111 Capital fully exited State Street SPDR Dow Jones Industrial Average ETF Trust in Q1 2026, selling an estimated $33.5M.
- 111 Capital's ten largest holdings make up 35% of its $406M portfolio in Q1 2026.
- 111 Capital opened 157 new positions and closed 151 in Q1 2026.
- 111 Capital's portfolio value fell 11% quarter-over-quarter to $406M.
Based on 111 Capital's 13F filing for Q1 2026, filed 11 May 2026.